EYLIA

Przegląd produktu

About EYLIA

EYLIA is a prescription medicine used in the field of ophthalmology. It is formulated as an injectable solution intended for administration by a qualified healthcare professional. This product is designed to address specific retinal conditions that can lead to vision impairment or loss. Patients should consult with an eye specialist to determine if this treatment is appropriate for their specific clinical diagnosis and medical history. The administration process occurs within a clinical setting to ensure proper sterile technique and monitoring.

Key Benefits & Uses

• Used for the treatment of neovascular age-related macular degeneration.
• Indicated for patients suffering from macular edema following retinal vein occlusion.
• Helps in the management of diabetic macular edema to preserve or improve visual acuity.

Active Ingredient & Action

The active ingredient in EYLIA is aflibercept. This substance functions as a vascular endothelial growth factor inhibitor. By binding to specific proteins in the eye, it helps to reduce the growth of abnormal blood vessels and decreases fluid leakage in the retina, which are primary factors in several sight-threatening conditions.

Important Notes

EYLIA must be administered by a physician experienced in intravitreal injections. Patients should report any symptoms of eye pain, redness, or sudden vision changes immediately following treatment. Always follow the specific dosing schedule provided by your medical provider.